CM
CM Management Portfolio holdings
AUM
$110M
This Quarter Return
+13.6%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$125M
AUM Growth
+$125M
(+15%)
Cap. Flow
+$8.79M
Cap. Flow
% of AUM
7.01%
Top 10 Holdings %
Top 10 Hldgs %
37.17%
Holding
71
New
8
Increased
24
Reduced
9
Closed
7
Top Buys
| 1 |
Rigel Pharmaceuticals
RIGL
|
$4.69M |
| 2 |
Copa Holdings
CPA
|
$1.64M |
| 3 |
Talos Energy
TALO
|
$1.55M |
| 4 |
Freeport-McMoran
FCX
|
$1.5M |
| 5 |
Park Hotels & Resorts
PK
|
$1.41M |
Top Sells
| 1 |
Baidu
BIDU
|
$2.59M |
| 2 |
Alibaba
BABA
|
$2.16M |
| 3 |
Newmark Group
NMRK
|
$1.55M |
| 4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$1.03M |
| 5 |
Hasbro
HAS
|
$878K |
Sector Composition
| 1 | Healthcare | 39.93% |
| 2 | Materials | 10.94% |
| 3 | Technology | 9.96% |
| 4 | Industrials | 9.07% |
| 5 | Financials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
CVS Health
CVS
$92.8B
| $2.2M | 1.76% | 35,000 +5,000 | +17% | +$314K |
|
|
27
Park Hotels & Resorts
PK
$2.35B
| $2.12M | 1.69% | 150,000 +100,000 | +200% | +$1.41M |
|
28
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $2.08M | 1.66% | 2,000,000 +900,000 | +82% | +$936K |
|
29
Organon & Co
OGN
$2.45B
| $1.91M | 1.53% | 100,000 -25,000 | -20% | -$478K |
|
30
First Financial Corporation Common Stock
THFF
$699M
| $1.86M | 1.49% | 42,500 +2,500 | +6% | +$110K |
|
|
WBA
31
DELISTED
Walgreens Boots Alliance
WBA
| $1.79M | 1.43% | 200,000 +50,000 | +33% | +$448K |
|
32
Pfizer
PFE
$141B
| $1.74M | 1.39% | 60,000 +10,000 | +20% | +$289K |
|
|
33
Copa Holdings
CPA
$4.83B
| $1.64M | 1.31% | +17,500 | New | +$1.64M |
|
34
Cohu
COHU
$929M
| $1.54M | 1.23% | 60,000 +30,000 | +100% | +$771K |
|
|
35
Freeport-McMoran
FCX
$63.7B
| $1.5M | 1.2% | +30,000 | New | +$1.5M |
|
36
Xoma
XOMA
$392M
| $1.46M | 1.16% | 55,000 | – | – |
|
37
Warner Bros
WBD
$28.8B
| $1.44M | 1.15% | 175,000 -25,000 | -13% | -$206K |
|
|
SVC
38
Service Properties Trust
SVC
$451M
| $1.37M | 1.09% | 300,000 | – | – |
|
39
Herc Holdings
HRI
$4.35B
| $1.28M | 1.02% | +8,000 | New | +$1.28M |
|
40
AMCON Distributing
DIT
$77.4M
| $1.21M | 0.96% | 8,333 +133 | +2% | +$19.3K |
|
41
Cytosorbents Corp
CTSO
$59.2M
| $1.2M | 0.96% | 800,000 -50,000 | -6% | -$75K |
|
42
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.08M | 0.86% | 70,000 +30,000 | +75% | +$461K |
|
43
Perrigo
PRGO
$3.27B
| $1.05M | 0.84% | +40,000 | New | +$1.05M |
|
44
Pan American Silver
PAAS
$12.3B
| $1.04M | 0.83% | 50,000 -25,000 | -33% | -$522K |
|
45
Heron Therapeutics
HRTX
$207M
| $995K | 0.79% | 500,000 +200,000 | +67% | +$398K |
|
46
Nektar Therapeutics
NKTR
$568M
| $975K | 0.78% | 750,000 | – | – |
|
47
Battalion Oil
BATL
$19.4M
| $934K | 0.75% | 140,000 | – | – |
|
48
Coya Therapeutics
COYA
$110M
| $929K | 0.74% | 144,059 +44,059 | +44% | +$284K |
|
49
Atea Pharmaceuticals
AVIR
$267M
| $905K | 0.72% | 270,000 | – | – |
|
50
Newell Brands
NWL
$2.48B
| $768K | 0.61% | 100,000 -75,000 | -43% | -$576K |
|